| J9271 | Injection, pembrolizumab, 1 mg | 10,200 | $40 | $357K |
| J0897 | Injection, denosumab, 1 mg | 3,240 | $20 | $58.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 540 | $90 | $47.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 27,000 | $1 | $27K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $90 | $17.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 120 | $140 | $16.9K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $160 | $9.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1,280 | $10 | $7.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 110 | $60 | $6.3K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 90 | $50 | $4.8K |